Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Maryland advocates press insurers to add FDA‑approved anti‑obesity drugs to formularies; sponsors emphasize long‑term cost savings
Summary
Supporters of HB 10 31 argued anti‑obesity medications can reduce long‑term chronic disease costs and urged insurers to put approved drugs on formularies (not necessarily full coverage); PBMs and carriers said plan sponsors decide coverage and urged negotiation; witnesses described patient experiences and raised equity concerns.
Delegate April Miller urged the Health and Government Operations Committee on Monday to support HB 10 31, legislation that would require insurers to include FDA‑approved anti‑obesity medications on plan formularies and thereby increase access for patients with clinically significant obesity.
Sponsor testimony and patients: Miller described obesity as a chronic disease with large social and economic costs and said new medicines can reduce inflammation, improve mobility and prevent progression to severe disease. She and patient witnesses gave personal…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
